Mode
Text Size
Log in / Sign up
N/A N=200 Randomized Health Services Research

Male Partner Engagement in HIV Testing Using Partner-notification Slip Plus Oral HIV Self-testing Kit

HIV Infections

Enrolled (actual)
200
Serious AEs
0.0%
Results posted
Apr 2026
Primary outcome: Primary: Proportion of Male Partners Who Reported to Clinic — 0.38; 0.32 proportion of male partners

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Partner Notification Slip plus HIV Self-test kit (Other); Partner Notification Slip only (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
University of North Carolina, Chapel Hill
Primary completion
Aug 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Proportion of Male Partners Who Reported to Clinic
0.38; 0.32
SECONDARY
Time Taken for Male Partners to Report to Clinic
7; 7 0.169

Summary

HIV testing uptake among male partners of pregnant women remains low. But the optimal way to engage the male partners is unknown. The antenatal setting, with nearly universal uptake of HIV testing for women, can serve as a way of reaching male partners. HIV self-testing (HIVST) is one approach to HIV testing that can be conducted out of health facility. HIVST is a rapid antibody test which can be performed by non-medical people and allows people to collect their own specimen, perform the test, and interpret the results in the privacy of their home or other preferred location. In this trial HIV-negative pregnant women who were attending antenatal care at Bwaila Hospital in Malawi will be randomized 1:1 to receive partner notification inviting their partners for clinic-based HIV testing (standard of care) or partner notification + HIV Self-test kit for partner testing at home (intervention).

Eligibility Criteria

Inclusion Criteria

  • HIV-negative pregnant woman
  • Must be available and willing to be contacted by phone within the next 30 days
  • Must be part of a heterosexual relationship for >3 months
  • Must expects their male sexual partner to be able to come to clinic in the next 30 days

Exclusion Criteria

  • unable to provide informed consent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT07488221). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search